Ambicare News
- One in Five Acne Sufferers Fears Leaving House
- Ambicare Health NICE statement
- Ambulight PDT Reaches Finals of International Design Awards
- Ambicare Health Appoints Dr Neil MacGilp as Non-Executive Director
- Ambicare plans new board appointments
- World’s First Skin Cancer Plaster Selected for NICE Consultation
- Ambicare Health commences European roll-out of Ambulight PDT
- Encouraging new independent research on the use of Ambulight PDT to treat skin cancer in Gorlin Syndrome Sufferers
- Presentation of new independent research on the use of Ambulight PDT to treat skin cancer in Gorlin Syndrome Sufferers
- Completion of £1.7 m fundraising and Appointment of Sales and Marketing Director
One in Five Acne Sufferers Fears Leaving House
UK research reveals two thirds concerned over side effects of acne treatments
Young women in their 20s and 30s suffering from acne find it increasingly difficult to deal with the effects of the condition according to a new national survey, which reveals that one in five don't like leaving the house as a result of having spots.
The new research, which has been undertaken by Ambicare Health, focuses on the growing number of young women between the ages of 20-39 suffering from acne. Over 73 per cent of those asked revealed that their acne makes them feel unattractive with 60 per cent left insecure as a consequence of having bad skin.
With over 80 per cent of the UK population suffering from acne at some point in their lives, there is a common misconception that most people will have the condition in their teens; however, there is an increase in the number of women affected by acne in their twenties and thirties. The research highlights that a significant proportion of these women are professional high earners who feel that spots are affecting their career aspirations.
The psychological impact of acne can be far reaching and today's findings indicate that many sufferers experience long term negative effects. Over half of respondents stated that bad skin has had an effect on their romantic relationships while one in four reported an impact on their career.
Concerns are growing over the long term risks associated with many systemic treatments and the adverse effects that can occur when the chemicals accumulate in the body over a period of time. Bacterial resistance is also a concern for patients and doctors, which is caused by the overuse of antibiotics. Today's research confirms this is an issue with over two thirds of UK respondents worried about the risks linked to them.
The findings coincide with the release of a breakthrough acne treatment called Lustre Pure Light which offers a completely safe solution for patients. Developed and tested by leading dermatologists and healthcare professionals specialising in skin conditions, the new light based device has been brought to market by Ambicare and is only available through specialist clinics.
Over two thirds of those taking part in the survey have visited a GP for acne advice with almost 30 per cent revealing that despite having used most acne treatments nothing has worked.
Dr Andrew McNeill, principle scientist at Ambicare, says: "Blue light is a proven technology invented by leading dermatologists and physicists that has been used successfully for many years as an acne treatment. The on-going issue for patients has been related to the accessibility and cost of this treatment, which results in the acne sufferer visiting the hospital or clinic up to 16 times for the recommended treatment dose with a potential cost of £800.
"Lustre Pure Light is a technological breakthrough and has been developed to answer this problem. The product will cut down waiting times and will deliver constant access to blue light technology in a hands free device that can be worn by the patient at home to keep the condition under control at a considerably reduced cost. Lustre has no risk of side effects using clinically proven technology to eliminate spot-causing bacteria, while also being gentle on skin."
Lustre is a small, rechargeable product with slim, flexible heads which directly targets problem areas. The device is portable and treatment is delivered while the product is worn, giving users the freedom to get on with everyday tasks.
Dr Ravi Jain Medical Director of Riverbanks Clinic in Harpenden has dispensed Lustre for a number of his patients. "A growing number of our patients with acne are concerned about the adverse side effects of current treatments as well as the potential long term risks associated with constant use and today's research confirms this. Lustre addresses this issue by offering a safe non systemic solution to patients but also compliments existing treatments prescribed by doctors and clinics. This device is a breakthrough for acne patients as for the first time people have the opportunity to use professional blue light technology at home."
Patients can find their nearest skincare clinic at www.lustrepurelight.com
26th January 2012
